Aimmune Therapeutics Inc is a clinical-stage biopharmaceutical company developing proprietary product candidates for the treatment of peanut, gastrointestinal, and metabolic-related diseases
Aimmune Therapeutics Inc is a clinical-stage biopharmaceutical company developing proprietary product candidates for the treatment of peanut, gastrointestinal, and metabolic-related diseases. The company conducts research and development in collaboration with leading biotechnology companies.
The top three firms on F4's Biotech & Life Sciences investor list.